The efficacy and tolerability of daily cream containing N-butanoyl-l-glutathione (GSH-C4), beta-glycyrrhetinic, and azelaic acid for treatment in patients with mild to moderate rosacea was evaluated.
Vyne Therapeutics announced the availability of Zilxi (minocycline) topical foam 1.5% for the treatment of inflammatory lesions of rosacea in adults.
The association of frontal fibrosing alopecia with demographic and exposition factors in a multiracial population was evaluated.
Epsolay is an investigational topical cream that utilizes the Company’s patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.
New data regarding the prevalence of skin disease in adults aged 70 and older, and the association of cutaneous
diseases and socioeconomic status, sex, and living status is provided.
Combination laser and intradermal botulinum toxin therapy for the management of rosacea is reported in this novel study.
Hypertension, dyslipidemia, and obesity were among the conditions investigators reviewed as being affected by the underlying inflammation associated with rosacea.
Dermatological disorders are extremely common in older individuals.
The use of PPE in the general population during the COVID-19 pandemic may be associated with the occurrence of facial dermatosis.
Skin redness and other symptoms associated with rosacea were found to improve with the use of a skincare regimen formulated for the treatment of centrofacial erythema.
